Clinical Trial Update: Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression [Phase 2]

View source ↗

Summary

Phase 2 trial update for Ammoxetine hydrochloride enteric-coated tablets in major depressive disorder is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ammoxetine Hydrochloride Enteric-coated Tablets (ammoxetine hydrochloride)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: UNKNOWN